Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vascular endothelial growth factor quantitative determination kit and light-emitting substrate solution thereof

A growth factor and vascular endothelial technology, applied in the field of vascular endothelial growth factor quantitative assay kit and its luminescent substrate solution, can solve the problem of photon intensity plateau period, poor stability of luminescent substrate solution by chemiluminescent method, and high signal-to-noise ratio question

Inactive Publication Date: 2014-08-06
山东一达生物科技有限公司
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the application of chemiluminescent method is greatly limited due to the disadvantages of poor stability of the luminescent substrate solution used, photon intensity plateau period, and high signal-to-noise ratio.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vascular endothelial growth factor quantitative determination kit and light-emitting substrate solution thereof
  • Vascular endothelial growth factor quantitative determination kit and light-emitting substrate solution thereof
  • Vascular endothelial growth factor quantitative determination kit and light-emitting substrate solution thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] 1. Mouse Immunization and Monoclonal Antibody Preparation

[0030] 1.1 Mouse immunization scheme: immunize a group of BALA / c mice with VEGF121, VEGF145, and VEGF165 antigens respectively, and there are two large groups in total, including VEGF derived from Escherichia coli and artificial short peptides; Two female balb / c mice aged 6-8 weeks in the group, set up four doses of immunization antigens: 200 μg, 100 μg, 50 μg, and 25 μg, two immunization methods: subcutaneous multi-point injection and intraperitoneal injection, and Freund’s adjuvant was used as the immune adjuvant And self-made adjuvant two kinds, immunization interval 2-3 weeks.

[0031] 1.2 Titer detection: 10-14 days after immunization, the blood was collected from the inner canthus of the mouse eyes, and the antibody titer was tested, and the cell fusion could be carried out only when the antibody titer reached 106.

[0032] 1.3 Cell fusion: Splenocytes from immunized mice were fused with myeloma cells. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a vascular endothelial growth factor quantitative determination kit and a light-emitting substrate solution thereof. The light-emitting substrate solution comprises a light emitting solution A and a light emitting solution B, wherein the light emitting solution A comprises the following ingredients with concentrations: 0.40-0.50 g / L luminol, 0.10-0.15 g / L p-iodophenol, 0.10-0.15 g / L 1,2-cyclohexanediamine tetraacetic acid, 4.60-5.40 g / L boric acid, 11.00-12.00 g / L borax, and 10.00-12.00 g / L sodium chloride; the light emitting solution B comprises the following ingredients with concentrations: 0.20-0.25 g / L urea peroxide, 1.00-1.50 ml / L Tween 20, 4.60-5.40 g / L boric acid, 11.00-12.00 g / L borax, and 10.00-12.00 g / L sodium chloride; a volume ratio of the light emitting solution A to the light emitting solution B during use is 1:1. The light-emitting substrate solution disclosed by the invention has the advantages of good stability, high sensitivity, and long photon strength platform period.

Description

technical field [0001] The invention relates to a protein immunodetection method, in particular to a kit for quantitative determination of vascular endothelial growth factor and a luminescent substrate solution thereof. Background technique [0002] Serum tumor markers (tpgmor markers, TM) refer to a class of substances produced by tumor cells themselves or by the body's response to tumor cells during the occurrence and proliferation of tumors, reflecting the existence and growth of tumors. Including proteins, hormones, enzymes (isoenzymes), polyamines and oncogene products. The detection of tumor markers is simple and less invasive, so it is widely used in tumor screening, diagnosis, and treatment. [0003] The growth and metastasis of cancer cells depend on the formation of new blood vessels, and vascular endothelial growth factor (VEGF) is the most effective factor for promoting angiogenesis (Ferrara et al. Endocr. Rev. 1997, 18: 4-25). Vascular endothelial growth facto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/68G01N21/76
CPCG01N33/57488G01N21/763G01N2333/515
Inventor 张从从钟晓玮
Owner 山东一达生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products